Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul;253(7):892-5.
doi: 10.1007/s00415-006-0126-y. Epub 2006 Apr 20.

Genetic heterogeneity in 30 German patients with oculopharyngeal muscular dystrophy

Affiliations

Genetic heterogeneity in 30 German patients with oculopharyngeal muscular dystrophy

T Müller et al. J Neurol. 2006 Jul.

Abstract

Oculopharyngeal muscular dystrophy (OPMD) is due to short elongations of a polyalanine tract in the poly(A) binding protein nuclear 1 (PABPN1) gene. Originally GCG expansions in which (GCG)(6) is extended to (GCG)(7-13) were found. Subsequently five further genotypes with additional GCA- and GCG-trinucleotides were identified in single OPMD patients. This indicated larger genetic heterogeneity and showed that unequal crossing-over and not replication slippage must be the underlying mechanism of elongation.We performed sequencing of the PABPN1 gene in 30 German OPDM index patients to determine the exact genotype. The original GCG expansion ranging from (GCG)(8) to (GCG)(11) was found in 22 patients. In 8 patients, however, three different elongated alleles other than classical (GCG)(7-13) were observed. Two of these genotypes had already been identified in Japanese patients. One genotype was recently identified showing (GCG)(6) followed by inserted (GCA)(3)GCG in four unrelated patients. This study further supports the theory of unequal crossing over as the molecular mechanism leading to elongation. It shows that other genotypes than classical (GCG)(7-13) are rather common in German OPMD patients. The data imply that there is no single founder effect in German OPMD patients.

PubMed Disclaimer

References

    1. Neurology. 2000 Nov 14;55(9):1267-70 - PubMed
    1. Hum Mol Genet. 1995 Mar;4(3):429-34 - PubMed
    1. Neuromuscul Disord. 2005 Feb;15(2):185-90 - PubMed
    1. Cytogenet Genome Res. 2003;100(1-4):252-60 - PubMed
    1. Ann Neurol. 1999 Jul;46(1):115-8 - PubMed

Substances

LinkOut - more resources